ArticleCancer innovation2025
Challenges in the Immune System: Mesoscale and Mesoregime Complexity.
Article in Cancer innovation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Nanoprobe-Enabled Precision Imaging and Panoramic Boundary Delineation in Retinoblastoma.Cancer innovation · 2026Review
- Unraveling the regulatory role of intercellular communication in intestinal immune cells mediated by H₂ in sepsis recovery through single-cell RNA sequencing.Journal of translational medicine · 2026Article
- Constructing Tumor Cellular Cluster Models and Their Evolutionary Dynamics to Decode Tumor Evolution.Cancer innovation · 2026Article
- Review
- Bridging Scales: Mesoscience as a Transformative Methodology.Cancer innovation · 2025Article
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One of the greatest challenges in bioscience is to gain a unified view of the human immune system. This paper presents a perspective on the multilevel and multiscale complexities inherent in the immune system and discusses how these features influence the traditional research methodologies rooted in reductionism and holism. It is acknowledged that diverse complexities of the immune system are multilevel in nature, with each level showing multiscale properties, and the complexity emerging always at mesoscales in mesoregimes. Mesoscience encompasses both mesoscales, which represent the intermediate scales between the element scales and system scales at different levels, and mesoregimes, defined as transitional regimes governed by the interplay of at least two dominant mechanisms between two limiting regimes at each level. Therefore, mesoscience provides a promising paradigm to study the complexity and diversity of the immune system by bridging the gaps across multiple hierarchical levels. In particular, we focus on the mesoscience methodology to address the complexities in the immune system and offer insights into potential diagnostic, therapeutic, and theranostic strategies for immune-related diseases from a mesoscience perspective.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.